The Statistical Center of the International Bone Marrow Transplant Registry (IBMTR) and the Autologous Blood and Marrow Transplant Registry of North America (ABMTR) coordinates an international effort to collect and analyze data on outcome of blood and bone marrow (hematopoietic stem cell) transplants. The IBMTR, established in 1972, and the ABMTR, established in 1990, involve >450 transplant centers in 47 countries. Participating centers submit data on consecutive transplants to the IBMTR/ABMTR Statistical Center. The Registries have data for >150,000 transplants. Statistical Center personnel have a strong record of expert and innovative analyses of HSCT issues using IBMTR/ABMTR and other data. This resource has been used extensively for determining transplant results in specific clinical situations, identifying prognostic factors, comparing transplant regimens, comparing transplant with non-transplant therapy, assessing intercenter variability in diagnosis, practice and outcome, planning clinical trials or treatment protocols, and developing approaches to evaluating transplant outcome. The proposed grant will support further development of this unique resource of data and statistical expertise. The proposal outlines several enhancements to the Statistical Center's data collection, entry and management system, including development of electronic data reporting systems and expansion of the database to include information on organizational characteristics of transplant centers and quality of life of long-term transplant survivors. It proposes educational and other efforts to improve the ability of centers to obtain follow-up on long-term survivors and a program to increase the use of this resource for planning and evaluating clinical trials. The project will also develop statistical methodologies appropriate for unbiased and efficient analyses of transplant data and provide expert statistical support for studies using IBMTR/ABMTR data.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA076518-07
Application #
6747713
Study Section
Subcommittee G - Education (NCI)
Program Officer
Wu, Roy S
Project Start
1998-03-01
Project End
2008-02-29
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
7
Fiscal Year
2004
Total Cost
$2,867,577
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Ahn, Kwang Woo; Sahr, Natasha; Kim, Soyoung (2018) Screening group variables in the proportional hazards model. Stat Probab Lett 135:20-25
Marsh, Rebecca A; Hebert, Kyle M; Keesler, Daniel et al. (2018) Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies. J Allergy Clin Immunol 142:2004-2007
Elgarten, Caitlin W; Arnold, Staci D; Li, Yimei et al. (2018) Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Infect Control Hosp Epidemiol 39:797-805
Strouse, Christopher; Zhang, Ying; Zhang, Mei-Jie et al. (2018) Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. Biol Blood Marrow Transplant 24:2072-2080
Shah, Nirav N; Ahn, Kwang Woo; Litovich, Carlos et al. (2018) Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis. Blood Adv 2:933-940
Eapen, Mary; Brazauskas, Ruta; Hemmer, Michael et al. (2018) Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity. Blood Adv 2:2095-2103
Lee, Catherine; Haneuse, Sebastien; Wang, Hai-Lin et al. (2018) Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation. PLoS One 13:e0190610
Keesler, Daniel A; St Martin, Andrew; Bonfim, Carmem et al. (2018) Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia. Biol Blood Marrow Transplant 24:2487-2492
Kumar, S K; Dispenzieri, A; Fraser, R et al. (2018) Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time. Leukemia 32:986-995
Sureda, Anna; Zhang, Mei-Jie; Dreger, Peter et al. (2018) Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. Cancer 124:1733-1742

Showing the most recent 10 out of 641 publications